A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

There are, besides remdesivir, no approved antivirals for the treatment of SARS-CoV-2 infections. To aid in the search for antivirals against this virus, we explored the use of human tracheal airway epithelial cells (HtAEC) and human small airway epithelial cells (HsAEC) grown at the air-liquid inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Do, Thuc Nguyen Dan, Donckers, Kim, Vangeel, Laura, Chatterjee, Arnab K., Gallay, Philippe A., Bobardt, Michael D., Bilello, John P., Cihlar, Tomas, De Jonghe, Steven, Neyts, Johan, Jochmans, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233549/
https://www.ncbi.nlm.nih.gov/pubmed/34186107
http://dx.doi.org/10.1016/j.antiviral.2021.105122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233549/
https://www.ncbi.nlm.nih.gov/pubmed/34186107
http://dx.doi.org/10.1016/j.antiviral.2021.105122

Ejemplares similares